NON-ALCOHOLIC FATTY LIVER DISEASE
Clinical trials for NON-ALCOHOLIC FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new NON-ALCOHOLIC FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for NON-ALCOHOLIC FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug XTYW007 targets fatty liver and cholesterol in early human tests
Disease control Not yet recruitingThis early-stage study tests a new drug called XTYW007 in healthy volunteers and people with high LDL-C (bad cholesterol) to see if it is safe and how the body processes it. The study also looks at how food affects the drug and its impact on blood fats and liver health. About 94 …
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: EARLY_PHASE1 • Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd. • Aim: Disease control
Last updated May 26, 2026 03:24 UTC
-
Could a diabetes pill help teens with fatty liver?
Disease control Not yet recruitingThis study tests whether a type 2 diabetes drug (SGLT2 inhibitor) can safely reduce liver fat in adolescents aged 12-20 who have obesity and non-alcoholic fatty liver disease (NAFLD). About 40 participants will receive either the drug or a placebo for several months. The main goa…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Justin Ryder • Aim: Disease control
Last updated May 26, 2026 03:11 UTC
-
AI vs. standard advice: which lifestyle plan wins for fatty liver?
Disease control Not yet recruitingThis study compares an artificial intelligence (AI)-driven lifestyle program to standard lifestyle advice for people with non-alcoholic fatty liver disease (NAFLD). The goal is to see if the AI approach helps more participants reduce liver fat by at least 30% over 12 months. The …
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated May 26, 2026 03:03 UTC
-
New drug duo aims to tackle fatty liver, obesity, and diabetes in one shot
Disease control Not yet recruitingThis early study will test whether adding a new drug (CS0159) to a standard diabetes medication (semaglutide) can help people with fatty liver disease, obesity, and type 2 diabetes lose weight and improve their health. About 30 adults will take the combination or a placebo for 12…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: NA • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 26, 2026 03:03 UTC
-
New computer tool aims to catch hidden fatty liver in the ER
Diagnosis Not yet recruitingThis study tests a computer tool that helps emergency doctors notice fatty liver on scans, tell patients, and recommend next steps. About 4,700 adults with fatty liver found on an ER scan will take part. The goal is to improve diagnosis and follow-up care for this often-overlooke…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: NA • Sponsor: Northwestern University • Aim: Diagnosis
Last updated May 26, 2026 02:48 UTC
-
Scientists probe Insulin's role in liver fat and sugar
Knowledge-focused Not yet recruitingThis study looks at how changing insulin levels affects the liver's production of sugar and fat in people with insulin resistance and fatty liver disease. About 36 adults with overweight or obesity will undergo two procedures where insulin is either kept high or lowered by half. …
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE1 • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC